Search
for
Sort by
Research 751–780 of 1000+
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Immunology of alopecia areata
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- New developments in the molecular treatment of ichthyosis: review of the literature
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021
- Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure
- Regenerative Medicine-Based Treatment for Vitiligo: An Overview
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
- Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Methods and Challenges in Purifying Drug‐Loaded Extracellular Vesicles
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- A “hair‐raising” history of alopecia areata
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- SIRT1 downregulation provokes immune-inflammatory responses in hair follicle outer root sheath cells and may contribute to development of alopecia areata
- Association of atopic dermatitis with autoimmune diseases: A bidirectional and multivariable two-sample mendelian randomization study
- The Future of Alopecia Treatment: Plant Extracts, Nanocarriers, and 3D Bioprinting in Focus
- Alopecia areata – Current understanding and management
- Analysing the dynamics of a model for alopecia areata as an autoimmune disorder of hair follicle cycling
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity
- Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model